A common diuretic wasn't much help for staving off recurrent kidney stones, the NOSTONE trial showed. Over a median follow-up of 2.9 years, symptomatic or radiologic recurrence of kidney stones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback